Literature DB >> 23510417

Direct binding to antigen-coated beads refines the specificity and cross-reactivity of four monoclonal antibodies that recognize polymorphic epitopes of HLA class I molecules.

H G Hilton1, P Parham.   

Abstract

Monoclonal antibodies with specificity for human leukocyte antigen (HLA) class I determinants of HLA were originally characterized using serological assays in which the targets were cells expressing three to six HLA class I variants. Because of this complexity, the specificities of the antibodies were defined indirectly by correlation. Here we use a direct binding assay, in which the targets are synthetic beads coated with 1 of 111 HLA class I variants, representing the full range of HLA-A, -B and -C variation. We studied one monoclonal antibody with monomorphic specificity (W6/32) and four with polymorphic specificity (MA2.1, PA2.1, BB7.2 and BB7.1) and compared the results with those obtained previously. W6/32 reacted with all HLA class I variants. MA2.1 not only exhibits high specificity for HLA-A*02, -B*57 and -B*58, but also exhibited cross-reactivity with HLA-A*11 and -B*15:16. At low concentration (1 µg/ml), PA2.1 and BB7.2 were both specific for HLA-A*02 and -A*69, and at high concentration (50 µg/ml) exhibited significant cross-reactions with HLA-A*68, -A*23 and -A*24. BB7.1 exhibits specificity for HLA-B*07 and -B*42, as previously described, but reacts equally well with HLA-B*81, a rare allotype defined some 16 years after the description of BB7.1. The results obtained with cell-based and bead-based assays are consistent and, in combination with amino acid sequence comparison, increase understanding of the polymorphic epitopes recognized by the MA2.1, PA2.1, BB7.2 and BB7.1 antibodies. Comparison of two overlapping but distinctive bead sets from two sources gave similar results, but the overall levels of binding were significantly different. Several weaker reactions were observed with only one of the bead sets.
© 2013 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23510417      PMCID: PMC3615166          DOI: 10.1111/tan.12095

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  38 in total

1.  Mutagenesis around residue 176 on HLA-B*0702 characterizes multiple distinct epitopes for anti-HLA antibodies.

Authors:  J A McCutcheon; C T Lutz
Journal:  Hum Immunol       Date:  1992-10       Impact factor: 2.850

2.  Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.

Authors:  Hugo G Hilton; Luca Vago; Anastazia M Older Aguilar; Achim K Moesta; Thorsten Graef; Laurent Abi-Rached; Paul J Norman; Lisbeth A Guethlein; Katharina Fleischhauer; Peter Parham
Journal:  J Immunol       Date:  2012-07-06       Impact factor: 5.422

3.  HLA antibody identification with single antigen beads compared to conventional methods.

Authors:  N El-Awar; J Lee; P I Terasaki
Journal:  Hum Immunol       Date:  2005-10-07       Impact factor: 2.850

4.  Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.

Authors:  Achim K Moesta; Paul J Norman; Makoto Yawata; Nobuyo Yawata; Michael Gleimer; Peter Parham
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

5.  Nucleotide sequence analysis of HLA-B*1523 and B*8101. Dominant alpha-helical motifs produce complex serologic recognition patterns for the HLA-B"DT" and HLA-B"NM5" antigens.

Authors:  M E Ellexson; G Zhang; D Stewart; M Lau; G Teresi; P Terasaki; B Roe; W Hildebrand
Journal:  Hum Immunol       Date:  1995-10       Impact factor: 2.850

6.  Molecular characterization of the new alleles HLA-B*8101 and B*4407.

Authors:  C Vilches; L Sanz; R de Pablo; M E Moreno; S Puente; M Kreisler
Journal:  Tissue Antigens       Date:  1996-02

7.  A new murine lymphocytotoxic monoclonal antibody recognizing HLA-A2, -A28 and -A9.

Authors:  S Mizuno; F Yako; H Ohta; T Kato; K Wada; C Uchigiri; M Furuta; K Ohya; T Kurachi; T Murase; T Kamiya; K Ozawa
Journal:  Tissue Antigens       Date:  1996-09

8.  A mAb against HLA-A2 can be influenced both positively and negatively by the associated peptide.

Authors:  D Barouch; M Davenport; A McMichael; P Reay
Journal:  Int Immunol       Date:  1995-10       Impact factor: 4.823

9.  Complete nucleotide sequence of HLA-B*0703, a B7 variant (BPOT).

Authors:  A M Bergmans; H Tijssen; N Lardy; P Reekers
Journal:  Hum Immunol       Date:  1993-10       Impact factor: 2.850

10.  Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C.

Authors:  J Zemmour; P Parham
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

View more
  9 in total

1.  A Distinctive Cytoplasmic Tail Contributes to Low Surface Expression and Intracellular Retention of the Patr-AL MHC Class I Molecule.

Authors:  Ana Goyos; Lisbeth A Guethlein; Amir Horowitz; Hugo G Hilton; Michael Gleimer; Frances M Brodsky; Peter Parham
Journal:  J Immunol       Date:  2015-09-14       Impact factor: 5.422

2.  Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells.

Authors:  Nicholas Aj Dawson; Caroline Lamarche; Romy E Hoeppli; Peter Bergqvist; Vivian Cw Fung; Emma McIver; Qing Huang; Jana Gillies; Madeleine Speck; Paul C Orban; Jonathan W Bush; Majid Mojibian; Megan K Levings
Journal:  JCI Insight       Date:  2019-03-21

3.  The production of KIR-Fc fusion proteins and their use in a multiplex HLA class I binding assay.

Authors:  Hugo G Hilton; Achim K Moesta; Lisbeth A Guethlein; Jeroen Blokhuis; Peter Parham; Paul J Norman
Journal:  J Immunol Methods       Date:  2015-06-19       Impact factor: 2.303

4.  Monitoring native HLA-I trimer specific antibodies in Luminex multiplex single antigen bead assay: Evaluation of beadsets from different manufacturers.

Authors:  Mepur H Ravindranath; Vadim Jucaud; Soldano Ferrone
Journal:  J Immunol Methods       Date:  2017-08-04       Impact factor: 2.303

5.  Structural and regulatory diversity shape HLA-C protein expression levels.

Authors:  Gurman Kaur; Stephanie Gras; Jesse I Mobbs; Julian P Vivian; Adrian Cortes; Thomas Barber; Subita Balaram Kuttikkatte; Lise Torp Jensen; Kathrine E Attfield; Calliope A Dendrou; Mary Carrington; Gil McVean; Anthony W Purcell; Jamie Rossjohn; Lars Fugger
Journal:  Nat Commun       Date:  2017-06-26       Impact factor: 14.919

6.  Concanamycin A counteracts HIV-1 Nef to enhance immune clearance of infected primary cells by cytotoxic T lymphocytes.

Authors:  Mark M Painter; Gretchen E Zimmerman; Madeline S Merlino; Andrew W Robertson; Valeri H Terry; Xuefeng Ren; Megan R McLeod; Lyanne Gomez-Rodriguez; Kirsten A Garcia; Jolie A Leonard; Kay E Leopold; Andrew J Neevel; Jay Lubow; Eli Olson; Alicja Piechocka-Trocha; David R Collins; Ashootosh Tripathi; Malini Raghavan; Bruce D Walker; James H Hurley; David H Sherman; Kathleen L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-08       Impact factor: 11.205

7.  High-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients' sera.

Authors:  Danilo Ritz; Andreas Gloger; Benjamin Weide; Claus Garbe; Dario Neri; Tim Fugmann
Journal:  Proteomics       Date:  2016-05       Impact factor: 3.984

8.  Single Molecule Force Spectroscopy Reveals Distinctions in Key Biophysical Parameters of αβ T-Cell Receptors Compared with Chimeric Antigen Receptors Directed at the Same Ligand.

Authors:  Debasis Banik; Maryam Hamidinia; Joanna Brzostek; Ling Wu; Hannah M Stephens; Paul A MacAry; Ellis L Reinherz; Nicholas R J Gascoigne; Matthew J Lang
Journal:  J Phys Chem Lett       Date:  2021-08-04       Impact factor: 6.888

Review 9.  Critical Review of Existing MHC I Immunopeptidome Isolation Methods.

Authors:  Alexandr Kuznetsov; Alice Voronina; Vadim Govorun; Georgij Arapidi
Journal:  Molecules       Date:  2020-11-19       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.